Markus J. Cappel, Chief Business Officer & Treasurer at ChemoCentryx, Inc. (CCXI), sold 330,224 shares at $30.77 ($10.6M) on 2019-11-26, disclosed to the SEC on 2019-11-27.
Open-market sale of $10.6M CCXI by Chief Business Officer & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.29 | 21,834 | $596K | 5.6% |
| 2 | $28.45 | 14,484 | $412K | 3.9% |
| 3 | $29.25 | 31,559 | $923K | 8.7% |
| 4 | $30.77 | 75,868 | $2.3M | 22.1% |
| 5 | $31.70 | 33,883 | $1.1M | 10.2% |
| 6 | $32.57 | 15,686 |
| $511K |
| 4.8% |
| 7 | $33.81 | 30,284 | $1.0M | 9.7% |
| 8 | $34.68 | 103,826 | $3.6M | 34.1% |
| 9 | $35.46 | 2,800 | $99K | 0.9% |
| Total | $32.02 avg | 330,224 | $10.6M | 100% |
| Filing → |
| CCXI | SELL | 2021-02-11 | $49K | — | Filing → |
| CCXI | SELL | 2021-02-08 | $1.2M | — | Filing → |
| CCXI | SELL | 2021-01-27 | $184K | — | Filing → |